摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one | 252722-35-3

中文名称
——
中文别名
——
英文名称
1-[1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one
英文别名
3-[1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]-1H-benzimidazol-2-one
1-[1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one化学式
CAS
252722-35-3
化学式
C18H18N6O
mdl
——
分子量
334.381
InChiKey
ORIMVPIFXCBEQV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    25
  • 可旋转键数:
    2
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    77.2
  • 氢给体数:
    2
  • 氢受体数:
    4

文献信息

  • Pyrrolo[2,3-d]pyrimidine compounds
    申请人:Pfizer inc.
    公开号:US20040058922A1
    公开(公告)日:2004-03-25
    A compound of the formula 1 wherein R 1 , R 2 and R 3 are as defined above, which are inhibitors of the enzyme protein tyrosine kinases such as Janus Kinase 3 and as such are useful therapy as immunosuppressive agents for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, Leukemia and other autoimmune diseases.
    该化合物的化学式为1,其中R1、R2和R3如上所定义,是蛋白酪氨酸激酶抑制剂,例如Janus Kinase 3,因此可作为免疫抑制剂用于器官移植、狼疮、多发性硬化症、类风湿性关节炎、屑病、1型糖尿病及糖尿病并发症、癌症、哮喘、特应性皮炎、自身免疫性甲状腺疾病、溃疡性结肠炎、克罗恩病、阿尔茨海默病、白血病和其他自身免疫性疾病的治疗。
  • Kinase Modulators and Methods of Use
    申请人:Anand Neel K.
    公开号:US20080076774A1
    公开(公告)日:2008-03-27
    The present invention relates to compounds of the Formula (I) and (II) wherein R, R 21 , R 25 -R 33 , m, n, X 21 -X 23 , and Q 1 are defined herein. The compounds modulate protein kinase enzymatic activity to modulate cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly p70S6 and/or Akt kinases. Methods of using and preparing the compounds, and pharmaceutical compositions thereof, to treat kinase-dependent diseases and conditions are also an aspect of the invention.
  • US6635762B1
    申请人:——
    公开号:US6635762B1
    公开(公告)日:2003-10-21
  • US7569569B2
    申请人:——
    公开号:US7569569B2
    公开(公告)日:2009-08-04
  • US8076338B2
    申请人:——
    公开号:US8076338B2
    公开(公告)日:2011-12-13
查看更多